[Postresuscitation restoration of central nervous system functions during systemic administration of new peptide analog of pyracetam].
Nazarenko
I V
IV
Kamenskiĭ
A A
AA
Gudasheva
T A
TA
Volkov
A V
AV
D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology; D001927:Brain Diseases / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D016887:Cardiopulmonary Resuscitation / Q000009:adverse effects*; D003250:Constriction; D003331:Coronary Vessels / Q000503:physiopathology; D004151:Dipeptides / Q000494:pharmacology*; D005106:Exploratory Behavior / Q000187:drug effects; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D018697:Nootropic Agents / Q000494:pharmacology*; D009949:Orientation / Q000187:drug effects; D051381:Rats
D004151:Dipeptides; D018697:Nootropic Agents; C103871:ethyl phenylacetyl-Pro-Gly
Postreanimatsionnoe vosstanovlenie funktsiĭ tsentral'noĭ nervnoĭ sistemy pri sistemnom vvedenii novogo peptidnogo analoga piratsetama.